fda
6 records
FDA Drug Recall: Sterile Water for Injection, USP, 30x5 mL Single-Dose Vials, Rx Only, Nephron 45
2023-03-08
Class II — CGMP Deviations: Potential product carryover.
View Source
FDA Drug Recall: 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only,
2023-02-01
Class II — CGMP Deviations: potential for trace amounts of product carryover.
View Source
FDA Drug Recall: Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vi
2023-02-01
Class II — CGMP Deviations: potential for trace amounts of product carryover.
View Source
FDA Drug Recall: S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Steril
2023-02-01
Class II — Short Fill
View Source
FDA Drug Recall: Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, US
2023-02-01
Class II — Short Fill
View Source
FDA Drug Recall: Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL si
2022-08-24
Class II — cGMP Deviations: deviations leading to potential cross-contamination.
View Source
nppes
1 records
ny_corps
1 records
NY Corp: NEPHRON SC, INC.
2017-02-23
FOREIGN BUSINESS CORPORATION | County: New York | Jurisdiction: South Carolina
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.